Evidence map›Paper›PMID 32631779›Full record

ArticleClinical lymphoma, myeloma & leukemia2020

Toxicities Associated With Metformin/Ritonavir Combination Treatment in Relapsed/Refractory Multiple Myeloma.

Nitya Nathwani, Joycelynne Palmer, Timothy W Synold, Behrouz Salehian, Michael Rosenzweig, James F Sanchez, Samantha N Hammond, Kehinde Adekola, Valeria Tomarchio, Arnab Chowdhury and 7 more

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical lymphoma, myeloma & leukemia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Nitya NathwaniJudy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA. Electronic address: nnathwani@coh.org.
Joycelynne PalmerDivision of Biostatistics, Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope, Duarte, CA; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
Timothy W SynoldDepartment of Cancer Biology, City of Hope, Duarte, CA.
Behrouz SalehianDepartment of Diabetes, Endocrinology and Metabolism, City of Hope, Duarte, CA.
Michael RosenzweigJudy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA.
James F SanchezJudy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA.
Samantha N HammondDepartment of Clinical Protocol Development, City of Hope, Duarte, CA.
Kehinde AdekolaDivision of Hematology/Medical Oncology, Northwestern University, Chicago, IL.
Valeria TomarchioJudy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA.
Arnab ChowdhuryJudy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA.
Chatchada KaranesJudy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA.
Myo HtutJudy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA.
Firoozeh SahebiJudy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA; Southern California Permanente Medical Group, Los Angeles, CA.
Tanya SiddiqiDepartment of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
Amrita KrishnanJudy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA.
Stephen J FormanDepartment of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
Steven T RosenDepartment of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
City of Hope · USLos Angeles Medical Center · USNorthwestern University · US

Funding

Small Animal Studies CoreP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · 1985 to 2025
$31.1M
NCI NIH HHS P30 CA033572
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Combined Modality TherapyFemaleHumansMetforminMiddle AgedMultiple MyelomaPilot ProjectsRitonavirMetforminRitonavirAdverse eventsGlucose transportersHematologic malignanciesNelfinavirProtease inhibitors

Identifiers

PMID32631779
PMCPMC7541704
OpenAlexW3028998546

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.